Quest DiagnosticsDGX
Diagnostics · NYSE · USA
$230.81
Up 1.7% todayClose
Up 30.8% this year and +10.0% since June 26, behind the life science sector at +10.7%. Quest Diagnostics supplies 1 mapped company and buys from 3.
About Quest Diagnostics
A nationwide lab network that does routine testing at volume, with more advanced diagnostics and health data work on top.
Theme exposure
Products
- Routine laboratory testing
- Advanced diagnostics
- Health data & insights
Competitors
- Labcorp
- Sonic Healthcare
- Exact Sciences
Risks
- Reimbursement pressure
- Competition from hospital labs
Same segment: Diagnostics
Tests, imaging and assays that support clinical decision-making. Segment 6 of 8 in the Medicine, pharma & life science value chain.
Compare DGX
Side by side with the largest companies in the same segment.
See where Quest Diagnostics sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.
Open the Life science value chain →